Peptide deformylase inhibitors with activity against respiratory tract pathogens

Bioorganic & Medicinal Chemistry Letters
2004.0

Abstract

A series of analogues of the peptide deformylase (PDF) inhibitor BB-3497 where the P3' amide bond was replaced with a ketone functionality is described. The in vitro antibacterial profiling of these compounds revealed that they demonstrate activity against pathogens associated with respiratory tract infections.

Knowledge Graph

Similar Paper

Peptide deformylase inhibitors with activity against respiratory tract pathogens
Bioorganic & Medicinal Chemistry Letters 2004.0
Asymmetric synthesis of bb-3497—A potent peptide deformylase inhibitor
Bioorganic & Medicinal Chemistry Letters 2001.0
Identification of novel potent bicyclic peptide deformylase inhibitors
Bioorganic & Medicinal Chemistry Letters 2004.0
Discovery of piperazic acid peptide deformylase inhibitors with in vivo activity for respiratory tract and skin infections
Bioorganic & Medicinal Chemistry Letters 2019.0
Hydroxamic Acid Derivatives as Potent Peptide Deformylase Inhibitors and Antibacterial Agents
Journal of Medicinal Chemistry 2000.0
New peptide deformylase inhibitors design, synthesis and pharmacokinetic assessment
Bioorganic & Medicinal Chemistry Letters 2016.0
Discovery and Refinement of a New Structural Class of Potent Peptide Deformylase Inhibitors
Journal of Medicinal Chemistry 2007.0
Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria
European Journal of Medicinal Chemistry 2014.0
Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition
Bioorganic & Medicinal Chemistry Letters 2001.0
A Novel Class of Inhibitors of Peptide Deformylase Discovered through High-Throughput Screening and Virtual Ligand Screening
Journal of Medicinal Chemistry 2004.0